ATG3, essential for LC3 lipidation, is upregulated in patients and mice with nonalcoholic fatty liver disease (NAFLD) and promotes lipid accumulation. The gene discussed is MAP1LC3A; the disease is metabolic dysfunction-associated steatotic liver disease.